FDA Approves First Drug for Functional Cure of Chronic Hepatitis B

The FDA has approved the first drug that achieves a functional cure for chronic hepatitis B, a major breakthrough for a disease affecting millions worldwide. The approval shifts the treatment paradigm from lifelong suppression to potential cure, though long-term durability and access remain uncertain. This marks a significant advancement in infectious disease management.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works